#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	5206	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2451	632.8	0	.	n	.	0	G1207A	SNP	1207	1207	G	1611	1611	A	756	A	662	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	5206	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2451	632.8	0	.	n	.	0	C1450T	SNP	1450	1450	C	1854	1854	T	739	T	665	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	5206	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2451	632.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1588	1588	C	760	C,A,G	653,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7682	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3879	593.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1853	1853	A	670	A	598	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7682	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3879	593.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2487	2487	C	729	C,T,G	638,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7682	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3879	593.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2561	2561	A	755	A	655	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7682	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3879	593.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3113	3113	C	666	C	578	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	630	folP	852	852	99.77	folP.l15.c4.ctg.1	1861	101.5	0	.	p	.	0	D71H	NONSYN	211	213	GAT	694	696	CAT	145;145;145	C;A;T,G	131;126;130,1	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	630	folP	852	852	99.77	folP.l15.c4.ctg.1	1861	101.5	0	.	p	.	0	A204V	NONSYN	610	612	GCA	1093	1095	GTA	142;142;142	G;T;A	124;126;126	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	630	folP	852	852	99.77	folP.l15.c4.ctg.1	1861	101.5	1	SNP	p	R228S	0	.	.	682	684	CGC	1165	1167	CGC	145;145;145	C;G;C	125;124;122	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1396	gyrA	2751	2751	99.78	gyrA.l6.c4.ctg.1	3733	111.9	0	.	p	.	0	M250I	NONSYN	748	750	ATG	1246	1248	ATA	127;127;129	A;T;A	114;111;115	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1396	gyrA	2751	2751	99.78	gyrA.l6.c4.ctg.1	3733	111.9	0	.	p	.	0	E883K	NONSYN	2647	2649	GAA	3145	3147	AAA	149;153;153	A,G;A;A	130,1;132;130	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1396	gyrA	2751	2751	99.78	gyrA.l6.c4.ctg.1	3733	111.9	1	SNP	p	S91F	0	.	.	271	273	TCC	769	771	TCC	128;128;128	T;C;C	112;115;115	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1396	gyrA	2751	2751	99.78	gyrA.l6.c4.ctg.1	3733	111.9	1	SNP	p	D95N	0	.	.	283	285	GAC	781	783	GAC	131;130;130	G;A;C,A	116;115;116,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1396	gyrA	2751	2751	99.78	gyrA.l6.c4.ctg.1	3733	111.9	1	SNP	p	D95G	0	.	.	283	285	GAC	781	783	GAC	131;130;130	G;A;C,A	116;115;116,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	568	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1596	106.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	376	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1258	89.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1428	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3349	128.0	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1685	1687	GTC	173;172;171	G;T;C	140;141;140	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1428	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3349	128.0	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1838	1840	GCA	155;155;155	G;C;A	135;136;135	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1428	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3349	128.0	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2321	2323	ATT	170;171;169	A;T;T	147;147;149	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1428	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3349	128.0	1	SNP	p	D86N	0	.	.	256	258	GAC	791	793	GAC	152;151;151	G;A;C	135;128;134	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1428	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3349	128.0	1	SNP	p	S87I	0	.	.	259	261	AGT	794	796	AGT	150;150;149	A;G;T	132;134;133	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1428	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3349	128.0	1	SNP	p	S87W	0	.	.	259	261	AGT	794	796	AGT	150;150;149	A;G;T	132;134;133	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1428	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3349	128.0	1	SNP	p	S87R	0	.	.	259	261	AGT	794	796	AGT	150;150;149	A;G;T	132;134;133	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1428	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3349	128.0	1	SNP	p	S88P	0	.	.	262	264	TCC	797	799	TCC	148;147;148	T;C;C	133;129;132	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1346	parE	1986	1986	99.85	parE.l15.c17.ctg.1	2989	135.0	0	.	p	.	0	E404G	NONSYN	1210	1212	GAA	1681	1683	GGA	161;161;162	G;G;A	140;139;144	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1346	parE	1986	1986	99.85	parE.l15.c17.ctg.1	2989	135.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1699	1701	GGC	166;164;165	G;G,A;C,A	147;141,1;140,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.1.001	penA.1.001	1	1	27	1356	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2641	153.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1369	1371	GCA	195;196;194	G,A;C;A	166,1;170;166	penA.1.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1356	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2641	153.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1372	1374	ATC	195;195;195	A;T;C	169;168;169	penA.1.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1356	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2641	153.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1384	1386	GTG	195;196;196	G;T,G;G	169;166,1;169	penA.1.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1356	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2641	153.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1384	1386	GTG	195;196;196	G;T,G;G	169;166,1;169	penA.1.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1356	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2641	153.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1888	1890	ACC	186;187;186	A;C;C	160;163;164	penA.1.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1356	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2641	153.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1942	1944	GCG	176;177;177	G,A;C;G	145,1;140;149	penA.1.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1356	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2641	153.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1942	1944	GCG	176;177;177	G,A;C;G	145,1;140;149	penA.1.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1356	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2641	153.6	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2065	2067	GGC	170;168;167	G,C;G;C	136,2;143;140	penA.1.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1356	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2641	153.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2074	2076	GGC	168;168;169	G;G;C,G	138;144;142,1	penA.1.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	1356	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2641	153.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2092	2094	CCG	169;169;170	C,G;C,A;G,C	140,2;146,1;141,1	penA.1.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1618	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3401	142.7	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1803	1805	CTG	176;176;176	C;T,C;G	144;144,1;146	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	646	porA	1146	1146	99.83	porA.l6.c17.ctg.1	2100	92.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	750	750	C	121	C	104	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	936	porB1b	1047	1047	98.66	porB1b.l15.c4.ctg.1	1873	148.1	0	.	p	.	0	T18M	NONSYN	52	54	ACG	560	562	ATG	196;196;198	A;T;G	161;162;163	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	936	porB1b	1047	1047	98.66	porB1b.l15.c4.ctg.1	1873	148.1	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	935	937	CAA	175;174;172	C,A;A;A	148,1;149;145	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	936	porB1b	1047	1047	98.66	porB1b.l15.c4.ctg.1	1873	148.1	0	.	p	.	0	E212D	NONSYN	634	636	GAA	1142	1144	GAT	172;172;172	G;A,T;T	155;154,1;155	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	936	porB1b	1047	1047	98.66	porB1b.l15.c4.ctg.1	1873	148.1	0	.	p	.	0	H213D	NONSYN	637	639	CAT	1145	1147	GAT	175;175;174	G;A,T;T	161;158,1;156	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	936	porB1b	1047	1047	98.66	porB1b.l15.c4.ctg.1	1873	148.1	0	.	p	.	0	V215A	NONSYN	643	645	GTT	1151	1153	GCT	173;174;174	G;CTT,CT;T	155;159,1;158	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	936	porB1b	1047	1047	98.66	porB1b.l15.c4.ctg.1	1873	148.1	0	.	p	.	0	S220T	NONSYN	658	660	AGC	1166	1168	ACT	180;180;178	A;C;T	160;160;157	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	936	porB1b	1047	1047	98.66	porB1b.l15.c4.ctg.1	1873	148.1	0	.	p	.	0	R257M	NONSYN	769	771	AGG	1277	1279	ATG	178;179;178	A;T;G	154;155;154	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	936	porB1b	1047	1047	98.66	porB1b.l15.c4.ctg.1	1873	148.1	0	.	p	.	0	R258S	NONSYN	772	774	AGG	1280	1282	AGC	176;177;177	A;G;C	151;154;154	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	936	porB1b	1047	1047	98.66	porB1b.l15.c4.ctg.1	1873	148.1	0	.	p	.	0	A259G	NONSYN	775	777	GCT	1283	1285	GGT	176;176;176	G;G;T	154;153;154	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	936	porB1b	1047	1047	98.66	porB1b.l15.c4.ctg.1	1873	148.1	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1397	1399	AAC	204;206;207	A,G;A;C	170,1;171;171	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	936	porB1b	1047	1047	98.66	porB1b.l15.c4.ctg.1	1873	148.1	1	SNP	p	G120K	0	.	.	358	360	GGC	866	868	GGC	183;184;184	G;G;C	159;159;154	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	3334	rpoB	4179	4179	100.0	rpoB.l6.c4.ctg.1	5232	191.2	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2170	2172	CAT	201;198;198	C;A;T	179;181;177	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	492	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1294	113.6	1	SNP	p	V57M	0	.	.	169	171	GTG	639	641	GTG	185;185;186	G;T;G	164;165;168	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
